These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22981928)

  • 1. Multi-targeted therapy for leprosy: insilico strategy to overcome multi drug resistance and to improve therapeutic efficacy.
    Anusuya S; Natarajan J
    Infect Genet Evol; 2012 Dec; 12(8):1899-910. PubMed ID: 22981928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homology modeling and docking analyses of M. leprae Mur ligases reveals the common binding residues for structure based drug designing to eradicate leprosy.
    Shanmugam A; Natarajan J
    J Mol Model; 2012 Jun; 18(6):2659-72. PubMed ID: 22102165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The eradication of leprosy: molecular modeling techniques for novel drug discovery.
    Anusuya S; Natarajan J
    Expert Opin Drug Discov; 2013 Oct; 8(10):1239-51. PubMed ID: 23924296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of site directed mutagenesis and secondary structure analysis predicts the amino acids essential for stability of M. leprae MurE.
    Shanmugam A; Natarajan J
    Interdiscip Sci; 2014 Mar; 6(1):40-7. PubMed ID: 24464703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invariant amino acids in the Mur peptide synthetases of bacterial peptidoglycan synthesis and their modification by site-directed mutagenesis in the UDP-MurNAc:L-alanine ligase from Escherichia coli.
    Bouhss A; Mengin-Lecreulx D; Blanot D; van Heijenoort J; Parquet C
    Biochemistry; 1997 Sep; 36(39):11556-63. PubMed ID: 9305945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
    Turk S; Kovac A; Boniface A; Bostock JM; Chopra I; Blanot D; Gobec S
    Bioorg Med Chem; 2009 Mar; 17(5):1884-9. PubMed ID: 19223185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
    Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
    Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).
    Perdih A; Hrast M; Barreteau H; Gobec S; Wolber G; Solmajer T
    Bioorg Med Chem; 2014 Aug; 22(15):4124-34. PubMed ID: 24953950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
    Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
    Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant leprosy: monitoring and current status.
    Williams DL; Gillis TP
    Lepr Rev; 2012 Sep; 83(3):269-81. PubMed ID: 23356028
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of drug-resistant strains of Mycobacterium leprae in an endemic area of Vietnam.
    Kai M; Nguyen Phuc NH; Nguyen HA; Pham TH; Nguyen KH; Miyamoto Y; Maeda Y; Fukutomi Y; Nakata N; Matsuoka M; Makino M; Nguyen TT
    Clin Infect Dis; 2011 Mar; 52(5):e127-32. PubMed ID: 21292655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of drug resistance in Mycobacterium leprae.
    Williams DL; Gillis TP
    Lepr Rev; 2004 Jun; 75(2):118-30. PubMed ID: 15282962
    [No Abstract]   [Full Text] [Related]  

  • 16. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
    Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
    Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance and multi-drug therapy in leprosy.
    Chatterjee BR
    Lepr India; 1982 Jul; 54(3):402-11. PubMed ID: 6757576
    [No Abstract]   [Full Text] [Related]  

  • 18. Search for effective short-course regimens for the treatment of leprosy.
    Pattyn SR
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):76-81. PubMed ID: 8326183
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis.
    Williams DL; Pittman TL; Gillis TP; Matsuoka M; Kashiwabara Y
    J Clin Microbiol; 2001 Jun; 39(6):2083-8. PubMed ID: 11376039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-drug therapy in leprosy.
    Girdhar BK
    Indian J Lepr; 1987; 59(2):145-51. PubMed ID: 3309084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.